AVASTIN 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
AVASTIN 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Pending
Register Number
04300002IP
Prescription Type
Uso Hospitalario
Authorization Date
Jan 21, 2022
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number04300002IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
BEVACIZUMABActive
Quantity: 25 mg
Name: BEVACIZUMAB
ATC CLASSIFICATION (3)
L01F
L01FG
L01FG01